Zoghbi Huda Y
Regeneron Pharmaceuticals Inc · Director
Zoghbi Huda Y is listed in filings as Director at Regeneron Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Feb 23, 2026, including sale activity. Recent filings connect the profile to Regeneron Pharmaceuticals Inc (REGN). The current snapshot covers public activity from Jan 6, 2025 to Feb 23, 2026. Reported amounts are shown as $617.0K to $233.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $258k331 shares | SellFeb 19, 2026 | $780.45 | $627.74 | |
| $233k298 shares | SellFeb 19, 2026 | $782.10 | $627.74 | |
| $3.2k4 shares | SellFeb 19, 2026 | $790.00 | $627.74 | |
| $172k220 shares | SellFeb 19, 2026 | $783.29 | $627.74 | |
| $163k209 shares | SellFeb 19, 2026 | $781.28 | $627.74 | |
| $162k208 shares | SellFeb 19, 2026 | $779.55 | $627.74 | |
| $126k160 shares | SellFeb 19, 2026 | $784.45 | $627.74 | |
| $44k56 shares | SellFeb 19, 2026 | $785.61 | $627.74 | |
| $41k53 shares | SellFeb 19, 2026 | $778.47 | $627.74 | |
| $39k50 shares | SellFeb 19, 2026 | $775.50 | $627.74 | |
| $38k49 shares | SellFeb 19, 2026 | $774.68 | $627.74 |